Showing results (161-170 of 169) with videos related to
Sort By:
Pageof 17
You have reached the last page of results.This site can display upto 169 results.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|October 2, 2007
Tissue plasminogen activator use: evaluation and initial management of ischemic stroke from an Iowa hospital perspectiveKaren C Albright, Todd C Schott, Neda Jafari, et al.British Journal of Rheumatology|June 1, 1989
Skin blood flow and limited joint mobility in insulin-dependent diabetes mellitusW S Mitchell, P H Winocour, R J Gush, et al.The Journal of Rheumatology|May 1, 1992
A double blind placebo controlled trial of recombinant tissue plasminogen activator in the treatment of digital ischemia in systemic sclerosisP S Klimiuk, E A Kay, K J Illingworth, et al.The Journal of Rheumatology|February 7, 1998
Ascorbic acid absorption in patients with systemic sclerosisL S Teh, C W Johns, J L Shaffer, et al.Annals of the Rheumatic Diseases|October 1, 1986
Antinuclear antibodies in the relatives and spouses of patients with systemic sclerosisP J Maddison, R P Skinner, R S Pereira, et al.Annals of the Rheumatic Diseases|April 1, 1990
Genes associated with rheumatoid arthritis and mild inflammatory arthritis. I. Major histocompatibility complex class I, II, and III allotypesA H Puttick, D C Briggs, K I Welsh, et al.Annals of the Rheumatic Diseases|February 1, 1992
A double blind, multicentre, placebo controlled trial of lornoxicam in patients with osteoarthritis of the hip and kneeH Berry, H A Bird, C Black, et al.Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|May 12, 2009
Acute stroke care in a neurologically underserved state: lessons learned from the Iowa Stroke SurveyKaren C Albright, Todd C Schott, Debbie F Boland, et al.The Journal of Rheumatology|October 21, 1999
A disease severity scale for systemic sclerosis: development and testingT A Medsger, A J Silman, V D Steen, et al.Pageof 17